CoChat
Sign Up
Cited by 205

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer Disease

Reitz, Christiane, Tang, Ming-Xin, Schupf, Nicole, Manly, Jennifer J., Mayeux, Richard, Luchsinger, José A.·2010·Archives of Neurology
DOI 10.1001/archneurol.2010.297PMC PMC3065942
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/archneurol.2010.297

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. [1]Hokanson JE Austin MA Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies J Cardiovasc Risk 1996 3 2 213 219 8836866
  2. [2]Fratiglioni L De Ronchi D Agüero-Torres H Worldwide prevalence and incidence of dementia Drugs Aging 1999 15 5 365 375 10600044
  3. [3]Luchsinger JA Reitz C Honig LS Tang MX Shea S Mayeux R Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology 2005 65 4 545 551 16116114 PMC1619350
  4. [4]Burns M Duff K Cholesterol in Alzheimer’s disease and tauopathy Ann N Y Acad Sci 2002 977 367 375 12480774
  5. [5]Sponne I Fifre A Koziel V Oster T Olivier JL Pillot T Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide FASEB J 2004 18 7 836 838 15001562
  6. [6]Michikawa M Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer’s disease? J Neurosci Res 2003 72 2 141 146 12671988
  7. [7]Anstey KJ Lipnicki DM Low LF Cholesterol as a risk factor for dementia and cognitive decline: a systematic review of prospective studies with meta-analysis Am J Geriatr Psychiatry 2008 16 5 343 354 18448847
  8. [8]Atzmon G Gabriely I Greiner W Davidson D Schechter C Barzilai N Plasma HDL levels highly correlate with cognitive function in exceptional longevity J Gerontol A Biol Sci Med Sci 2002 57 11 M712 M715 12403798
  9. [9]Goldstein FC Ashley AV Endeshaw YW Hanfelt J Lah JJ Levey AI Effects of hypertension and hypercholesterolemia on cognitive functioning in patients with Alzheimer disease Alzheimer Dis Assoc Disord 2008 22 4 336 342 19068499 PMC2634658
  10. [10]Haag MD Hofman A Koudstaal PJ Stricker BH Breteler MM Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity: the Rotterdam Study J Neurol Neurosurg Psychiatry 2009 80 1 13 17 18931004
  11. [11]Hajjar I Schumpert J Hirth V Wieland D Eleazer GP The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment J Gerontol A Biol Sci Med Sci 2002 57 7 M414 M418 12084801
  12. [12]Helzner EP Luchsinger JA Scarmeas N Contribution of vascular risk factors to the progression in Alzheimer disease Arch Neurol 2009 66 3 343 348 19273753 PMC3105324
  13. [13]Kivipelto M Helkala EL Hänninen T Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study Neurology 2001 56 12 1683 1689 11425934
  14. [14]Kivipelto M Solomon A Cholesterol as a risk factor for Alzheimer’s disease: epidemiological evidence Acta Neurol Scand Suppl 2006 185 50 57 16866911
  15. [15]Kontush A Chapman MJ HDL: close to our memories? Arterioscler Thromb Vasc Biol 2008 28 8 1418 1420 18650505
  16. [16]Kuo YM Emmerling MR Bisgaier CL Elevated low-density lipoprotein in Alzheimer’s disease correlates with brain abeta 1-42 levels Biochem Biophys Res Commun 1998 252 3 711 715 9837771
  17. [17]Kuriyama M Hokezu Y Togo S Serum lipids, lipoproteins and apolipoproteins in patients with senile dementia [in Japanese] Nippon Ronen Igakkai Zasshi 1992 29 7–8 559 564 1434052
  18. [18]Kuriyama M Takahashi K Yamano T Low levels of serum apolipoprotein A I and A II in senile dementia Jpn J Psychiatry Neurol 1994 48 3 589 593 7891423
  19. [19]Lesser G Kandiah K Libow LS Elevated serum total and LDL cholesterol in very old patients with Alzheimer’s disease Dement Geriatr Cogn Disord 2001 12 2 138 145 11173887
  20. [20]Li L Cao D Desmond R Cognitive performance and plasma levels of homocysteine, vitamin B12, folate and lipids in patients with Alzheimer disease Dement Geriatr Cogn Disord 2008 26 4 384 390 18931498 PMC2679366
  21. [22]Moroney JT Tang MX Berglund L Low-density lipoprotein cholesterol and the risk of dementia with stroke JAMA 1999 282 3 254 260 10422994
  22. [23]Muckle TJ Roy JR High-density lipoprotein cholesterol in differential diagnosis of senile dementia Lancet 1985 1 8439 1191 1193 2860390
  23. [24]Panza F Capurso C D’Introno A Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer’s disease J Am Geriatr Soc 2007 55 1 133 135 17233704
  24. [25]Raffaitin C Gin H Empana JP Metabolic syndrome and risk for incident Alzheimer’s disease or vascular dementia: the Three-City Study Diabetes Care 2009 32 1 169 174 18945929 PMC2606808
  25. [26]Shobab LA Hsiung GY Feldman HH Cholesterol in Alzheimer’s disease Lancet Neurol 2005 4 12 841 852 16297842
  26. [27]Solfrizzi V Panza F Colacicco AM Italian Longitudinal Study on Aging Working Group Vascular risk factors, incidence of MCI, and rates of progression to dementia Neurology 2004 63 10 1882 1891 15557506
  27. [28]Teunissen CE De Vente J von Bergmann K Serum cholesterol, precursors and metabolites and cognitive performance in an aging population Neurobiol Aging 2003 24 1 147 155 12493560
  28. [29]van Exel E de Craen AJ Gussekloo J Association between high-density lipoprotein and cognitive impairment in the oldest old Ann Neurol 2002 51 6 716 721 12112077
  29. [30]Yaffe K Barrett-Connor E Lin F Grady D Serum lipoprotein levels, statin use, and cognitive function in older women Arch Neurol 2002 59 3 378 384 11890840
  30. [31]Zuliani G Ble’ A Zanca R Lipoprotein profile in older patients with vascular dementia and Alzheimer’s disease BMC Geriatr 2001 1 5 11806756 PMC64782
  31. [33]Reitz C Tang MX Manly J Schupf N Mayeux R Luchsinger JA Plasma lipid levels in the elderly are not associated with the risk of mild cognitive impairment Dement Geriatr Cogn Disord 2008 25 3 232 237 18264008 PMC2725016
  32. [34]Reitz C Luchsinger J Tang MX Manly J Mayeux R Impact of plasma lipids and time on memory performance in healthy elderly without dementia Neurology 2005 64 8 1378 1383 15851727 PMC2737324
  33. [35]Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 1994 344 8934 1383 1389 7968073
  34. [36]Tang MX Stern Y Marder K The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics JAMA 1998 279 10 751 755 9508150
  35. [37]Stern Y Andrews H Pittman J Diagnosis of dementia in a heterogeneous population: development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education Arch Neurol 1992 49 5 453 460 1580806
  36. [38]Honig LS Tang MX Albert S Stroke and the risk of Alzheimer disease Arch Neurol 2003 60 12 1707 1712 14676044
  37. [39]McKhann G Drachman D Folstein M Katzman R Price D Stadlan EM Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease Neurology 1984 34 7 939 944 6610841
  38. [41]Friedewald WT Levy RI Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 1972 18 6 499 502 4337382
  39. [43]Hixson JE Vernier DT Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI J Lipid Res 1990 31 3 545 548 2341813
  40. [44]Chobanian AV Bakris GL Black HR National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 2003 289 19 2560 2572 12748199
  41. [45]Sacco RL Benson RT Kargman DE High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study JAMA 2001 285 21 2729 2735 11386928
  42. [46]Sacco RL Benjamin EJ Broderick JP American Heart Association Prevention Conference, IV: prevention and rehabilitation of stroke. risk factors Stroke 1997 28 7 1507 1517 9227708
  43. [47]Snowdon DA Greiner LH Mortimer JA Riley KP Greiner PA Markesbery WR Brain infarction and the clinical expression of Alzheimer disease: the Nun Study JAMA 1997 277 10 813 817 9052711
  44. [48]Sharrett AR Patsch W Sorlie PD Heiss G Bond MG Davis CE Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study Arterioscler Thromb 1994 14 7 1098 1104 8018665
  45. [49]Breteler MM Claus JJ Grobbee DE Hofman A Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study BMJ 1994 308 6944 1604 1608 8025427 PMC2540432
  46. [50]Reid PC Urano Y Kodama T Hamakubo T Alzheimer’s disease: cholesterol, membrane rafts, isoprenoids and statins J Cell Mol Med 2007 11 3 383 392 17635634 PMC3922347
  47. [51]Dietschy JM Turley SD Cholesterol metabolism in the brain Curr Opin Lipidol 2001 12 2 105 112 11264981
  48. [52]Lewis GF Steiner G Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus Diabetes Metab Rev 1996 12 1 37 56 8861500
  49. [53]Mooradian AD Dyslipidemia in type 2 diabetes mellitus Nat Clin Pract Endocrinol Metab 2009 5 3 150 159 19229235
  50. [54]Luchsinger JA Tang M-X Shea S Mayeux R Hyperinsulinemia and risk of Alzheimer disease Neurology 2004 63 7 1187 1192 15477536
  51. [55]Craft S Insulin resistance and Alzheimer’s disease pathogenesis: potential mechanisms and implications for treatment Curr Alzheimer Res 2007 4 2 147 152 17430239
  52. [56]Henderson VW Guthrie JR Dennerstein L Serum lipids and memory in a population based cohort of middle age women J Neurol Neurosurg Psychiatry 2003 74 11 1530 1535 14617710 PMC1738219
  53. [57]Sparks DL Schreurs BG Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer’s disease Proc Natl Acad Sci U S A 2003 100 19 11065 11069 12920183 PMC196927
  54. [58]Schreurs BG Smith-Bell CA Lochhead J Sparks DL Cholesterol modifies classical conditioning of the rabbit (Oryctolagus cuniculus) nictitating membrane response Behav Neurosci 2003 117 6 1220 1232 14674842
  55. [59]Gibellato MG Moore JL Selby K Bower EA Effects of lovastatin and pravastatin on cognitive function in military aircrew Aviat Space Environ Med 2001 72 9 805 812 11565814
  56. [60]Muldoon MF Barger SD Ryan CM Effects of lovastatin on cognitive function and psychological well-being Am J Med 2000 108 7 538 546 10806282
  57. [61]Cooper R Cutler J Desvigne-Nickens P Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention Circulation 2000 102 25 3137 3147 11120707
  58. [62]Grundy SM Cleeman JI Daniels SR American Heart Association; National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 2005 112 17 2735 2752 16157765
  59. [63]Corti MC Guralnik JM Salive ME HDL cholesterol predicts coronary heart disease mortality in older persons JAMA 1995 274 7 539 544 7629981
  60. [64]Scacchi R De Bernardini L Mantuano E DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer’s disease Dement Geriatr Cogn Disord 1998 9 4 186 190 9681639
  61. [65]Stewart R White LR Xue QL Launer LJ Twenty-six-year change in total cholesterol levels and incident dementia: the Honolulu-Asia Aging Study Arch Neurol 2007 64 1 103 107 17210816

Cited by

Sorted by citations

Metadata

Authors
Reitz, C., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A.
Venue
Archives of Neurology
Publisher
American Medical Association (AMA)
Published
2010-12-01
Volume
67
Issue
12
ISSN
0003-9942
DOI
10.1001/archneurol.2010.297
PMC
PMC3065942
Cited by
205
References
5
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review